VI.REL Pharma was founded in 1997 as a specialized consulting firm in the field of drug R&D.
Today, the VI.REL group consists of a team of international professionals with multidisciplinary experience, combining scientific, medical and regulatory knowledge.
VI.REL performs pharmacovigilance, regulatory intelligence, Module 1 and 2 registration dossier writing, document management in e-CTD format, and European-recognized medical writing activities.

Paolo Biffignandi

Scientific Director, Principal Medical Writer, QPPV.

Lorella Carletto

Regulatory Officer, Deputy QPPV.

Virginia Biffignandi

Safety Officer, Quality Assurance.

Claudia Moia

Regulatory Affairs Assistant.

Krystian Krysinski

Pharmacovigilance Specialist and Deputy QPPV.